Part 1
Every health care organization collects data from its patients, and with access to this data comes the responsibility of securing and using data in applications that are ethical, legal, and with studied outcomes. While organizational health information management supports many of these responsibilities, the decision makers ultimately shape an organization and its future. In this assessment, you analyze the data provided and consider its potential impact in the scenario.
At the Master’s level, all written assignments are expected to be formal research papers in APA format. A formal paper will have an introduction, body, and conclusion. The introduction should have a thesis that consists of a hypothesis or concepts that will be supported with research in the body of the paper. All assignments require at least 2 expert references.
Submit all written assignments as APA formatted MS Word documents.
Feedback on your assignments will be embedded in the body of the returned paper. You are expected to demonstrate improvement with every assignment.
Part I: Cases by City
Read the following scenario:
Data has been collected to identify specific cases of people who are infected with a dangerous virus. Your organization has an interest in knowing where the population is most affected in an effort to move resources to areas that need them.
Create a bar chart using Microsoft Excel® and the data provided in the Cases by City spreadsheet to identify the cities with the highest counts of cases.
Write a 525- to 700-word analysis of the data. Include an answer to the following questions:
- What are the top 5 cities for infected cases?
- How many infected cases do each of those cities have?
- What is the prevalence rate per 100,000 people?
- What else can be deduced after evaluating the chart?
Include your bar chart with the analysis.
Part II: Ages Impacted
Now that we know where the outbreaks are located, your organization wants to know more about who it affects. The age of the patient will determine what kind of resources will be needed in those areas.
Create a side-by-side bar graph using Microsoft Excel® and the data provided in the Ages Impacted spreadsheet to identify the age groups affected by the virus.
Note: This information will be used for further analysis in future assessments.
Write a 525- to 700-word analysis of the data. Include an answer to the following questions:
- Which age groups are most affected?
- Which age groups are least affected?
- What is the prevalence rate per age demographic?
- What else can be deduced after evaluating the chart?
Include your side-by-side bar graph with the analysis.
Format your citations according to APA guidelines.
Compile Part I and Part II into a report that could be submitted to the leadership in your organization.
Submit your assignment.
PART2
Respond to the following in a minimum of 175 words:
- Should all clinical data be made available to the public? Why or why not? Research and provide examples of how patient data that has been made public has been used. Defend your answer by citing 2 to 3 reputable sources.
Respond to classmates: 50 words minimum
R1
I would say that clinical data should be made available to the public but with the proper steps taken to make sure the information is used for the purpose of research. There could be a way that the records could be requested and to ensure the data is being used exactly what it should be used for. When patients are involved in clinical trials it is important for the researcher and regulators to have access to the patients information so they are able to track the patients prior health problems before the trial. Having the ability to see clinical data from other researches would allow analysts outside and inside the drug companies to combine their data findings from several different studies, to create a larger database that can be used for current studies along with future studies. Also, by allowing clinical data to be used in the public this will allow scientists to better understand some of the new medications and how safe they actually will be for individuals to take them. Being able to get more informational research by using clinical data could help design new medication and trials that could save more lives.
http://ethics.harvard.edu
http://www.ncbi.nlm.nih.gov
R2
There are great things that can occur or be learned from the clinical data. Take for instance if the public had all the knowledge about the COVID-19 clinical trials up front then some people could have avoided the loss they have faced because of the adverse events that happen when taking the vaccine. Keeping people in the dark to get them to do the things others want them to do is never right. Having the data available to the public builds trust, knowledge, and a better way to brainstorm if the majority doesn’t agree with what is begin put forth. I for one was on the fence about the COVID vaccine because it wasn’t too many studies on what effect the vaccine would have on someone that has hypothyroidism. They had studies of people who were completely healthy and after they received both doses they began to develop hypothyroidism. So I was like what happens to the person that actually has this autoimmune disorder and they take the vaccine. Does it make it better or worse? These are questions that most people need to have the answer to if they are trying to force everyone to get. This is just my take.
References:
Should There Be Public Access to Data from Clinical Trials | Edmond J. Safra Center for Ethics (harvard.edu)
The Final Rule: clinical trial data to be made public (outsourcing-pharma.com)
Thyroid dysfunction following vaccination with COVID-19 vaccines: a basic review of the preliminary evidence – PMC (nih.gov)
